Прилучный С. В.¹, Федосеева Е. С.², Брынова О. В.¹, Фурминская Е. Ю.², Гриневич В. Н.^{2, 3}

¹ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами президента РФ; Россия, 121359 Москва, ул. Маршала Тимошенко, 15;

²Медицинский радиологический научный центр им. А. Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, 249031 Обнинск, ул. Маршала Жукова, 10;

³Московский научно-исследовательский онкологический институт им. П. А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, 125284 Москва, 2‑й Боткинский пр-д, 3

1. Wadha B., Mohan A., Agarwal A.K. et al. A study of malignant serous effusions in a tertiary teaching hospital in western Uttar Pradesh. Indian J Pathol Oncol 2016;3(2):276–80. DOI: 10.5958/2394-6792.2016.00053.3

2. Chandra A. Announcement: the international system for reporting serous fluid cytopathology. Acta Cytol 2019;63(5):349–51. DOI: 10.1111/cyt.13218

3. Chandra A., Crothers B., Kurtycz D., Schmitt F. The International System for Serous Fluid Cytopathology. Heidelberg: Springer Nature, 2020. 301 p. DOI: 10.1007/978-3-030-53908-5

4. Международная система классификации цитопатологии серозных жидкостей (TIS RSFC). Под ред. А. Чандра, Б. Кротерс, Д. Куртич, Ф. Шмитт. Пер. с англ. под ред. Е.С. Федосеевой. М.: Практическая медицина, 2023. 416 с. The International System for Reporting Serous Fluid Cytopathology (TIS RSFC). Eds.: A. Chandra, B. Crothers, D. Kurtycz, F. Schmitt. Translated from English by E.S. Fedoseeva. Moscow: Prakticheskaya meditsina, 2023. 416 p. (In Russ.).

5. Song M.J., Jo U., Jeong J.S. et al. Clinico-cytopathologic analysis of 574 pericardial effusion specimens: application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up. Cancer Med 2021;10(24):8899–908. DOI: 10.1002/cam4.4408

6. Wang M., Chandra A., Cai G. The International System for Reporting Serous Fluid Cytopathology – an updated review. J Clin Transl Pathol 2023;3(4):160–77. DOI: 10.14218/JCTP.2023.00025

7. Viljanen E., Kholová I., Chandra A. Practical approach to reporting based on the International System for Serous Fluid Cytopathology. Cytopathology 2025;36(1):12–22. DOI: 10.1111/cyt.13450

8. Li J.J.X., Cheung W., Ng J.K.M. et al. Application of algorithmic cytomorphological assessment and immunocytochemistry with the international system for reporting serous fluid cytopathology on pericardial fluid cytology. J Clin Pathol 2024;77(11):766–71. DOI: 10.1136/jcp-2023-209078

9. Григорук О.Г., Вихлянов И.В., Базулина Л.М. и др. Цитодиагностика плевральных выпотов в соответствии с Международной классификацией цитопатологии серозных жидкостей: ретроспективный анализ опыта онкологического диспансера. Онкология 2024;25(1):60–7. DOI: 10.17816/onco546017 Grigoruk O.G., Vikhlyanov I.V., Bazulina L.M. et al. Cytodiagnostics of pleural effusions in accordance with the international system for reporting serous fluid cytopathology: a retrospective analysis of the experience of an oncology dispensary. Onkologiya = Oncology 2024;25(1):60–7. (In Russ.). DOI: 10.17816/onco546017

10. Круглова И.А., Зиновьев С.В., Уткин О.В. и др. Комплексный подход в цитоморфологической диагностике экссудатов при раке яичников с использованием биочип тест-системы SER-1. Поволжский онкологический вестник 2023;4(56). Kruglova I.A., Zinov’ev S.V., Utkin O.V. et al. Complex approach to cytomorphological diagnostics of exudates in ovarian cancer using the SER-1 biochip test system. Povolzhskiy onkologicheskiy vestnik = Volga Region Oncological Herald 2023;4(56). (In Russ.).

11. Farahani S.J., Baloch Z. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagn Cytopathol 2019;47(11):1145–59. DOI: 10.1002/dc.24278

12. Psallidas I., Kalomenidis I., Porcel J.M. et al. Malignant pleural effusion: from bench to bedside. Eur Respir Rev 2016;25(140): 189–98. DOI: 10.1183/16000617.0019-2016

13. Kremer R., Best L.A., Savulescu D. et al. Pleural fluid analysis of lung cancer versus benign inflammatory disease patients. Br J Cancer 2010;102(7):1180–4. DOI: 10.1038/sj.bjc.6605607

14. Loveland P., Christie M., Hammerschlag G. et al. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary center experience. Intern Med J 2018;48(11):1318–24. DOI: 10.1111/imj.13991

15. Rossi E.D., Bizzarro T., Schmitt F. et al. The role of liquid-based cytology and ancillary techniques in pleural and pericardial effusions: an institutional experience. Cancer Cytopathol 2015;123(4):258–66. DOI: 10.1002/cncy.21518

16. Ohwada M., Suzuki M., Suzuki T. et al. Problems with peritoneal cytology in second-look laparotomy performed in patients with epithelial ovarian cancer. Ca

ncer 2001;93(6):376–80. DOI: 10.1002/cncr.10137 17. Montavon Sartorius C., Mirza U., Schotzau A. et al. Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers. Cancer Manag Res 2018;10:4709–18. DOI: 10.2147/CMAR.S174777

18. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 2.2025. Published May 23, 2025. Accessed July 14, 2025. Available at: https://www.nccn.org/professionals/physician_ gls/pdf/ovarian.pdf

19. Nakagawa S., Nashimoto A., Yabusaki H. Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer 2007;10(1):29–34. DOI: 10.1007/s10120-006-0406-3

20. Serous effusions – etiology, diagnosis, prognosis and therapy. Eds.: B. Davidson, P. Firat, C.M. Michael. London: Springer, 2018. 306 p. DOI: 10.1007/978-3-319-76478-8